Flagship explainer

How RenovoRx, Inc. makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$1.1M · 100%Cost of revenue$327000 · 29%Gross profit$796000 · 71%Operating income−$12.5M · −1114%Income before tax−$11.2M · −994%Income tax$2000 · 0%Net income−$11.2M · −994%As of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$1.1M100%
Cost of revenue$32700029%
$79600071%
−$12.5M−1114%
Income before tax−$11.2M−994%
Income tax$20000%
−$11.2M−994%
Source: · event Dec 31, 2025 · retrieved Jul 26, 2026 · annual-row source set
Embed this chart

View the full RenovoRx, Inc. analysis at Buy Like Buffett